- An extensive, multi-national market research study on the HPV virus amongst 15,000 Europeans in 10 countries
- One in three respondents have never heard of HPV and only 3% who had heard of HPV were aware that most people will contract HPV in their lifetime
- Just over half of all respondents that were aware of HPV (51%) didn’t agree or didn’t know that HPV could cause cancer in males
- Research undertaken by Ipsos, the global market research firm, on behalf of MSD
A large-scale Ipsos market research study taking place in 10 European countries, demonstrated substantial knowledge and awareness differences around the human papillomavirus (HPV). 15,000 men and women in 10 European countries took part in this significant study conducted by global market research firm Ipsos, on behalf of MSD.
Nearly all cervical cancers (99.7%) are caused by infection with a high-risk type of HPV. It is the fourth-most frequent cancer in women and has a high mortality rate globally, according to the World Health Organisation (WHO). In addition, HPV infections are responsible for a range of non-cervical diseases in both men and women that have serious morbidity and contribute to a substantial healthcare burden.
Highlights from this comprehensive study included:
- Mixed awareness of HPV across Europe
- Misunderstanding about how common the HPV virus is
- Many respondents were not aware that men are at risk of contracting HPV and HPV-related cancers
Helen Cox, senior director, Ipsos Healthcare, added, “This market research is a comprehensive study into the awareness and perceptions of the human papillomavirus (HPV) including 15,000 adults (16-60 years) across 10 countries in Europe. This survey provides robust benchmarks of levels of awareness and knowledge of HPV across the 10 European countries and perhaps, more significantly, an understanding of how this differs between these countries”.
In addition to cervical cancer, HPV infections are responsible for a range of non-cervical diseases in both sexes that have serious morbidity and contribute to a substantial healthcare burden.